Research News and Research

RSS

Study reveals elevated risk of type 2 diabetes in South Asians than other Asian immigrants

South Asians living in the United States are at much higher risk for type 2 diabetes than are whites and immigrants from other Asian countries, a new small study reveals.

23 Sep 2010

Arrowhead increases ownership in Calando Pharmaceuticals through Series A Preferred Stock exchange

Arrowhead Research Corporation today announced that it has increased its ownership of majority owned subsidiary Calando Pharmaceuticals through the exchange of Calando Series A Preferred Stock for Arrowhead warrants.

23 Sep 2010

Tolerx presents otelixizumab preclinical research at 46th EASD

Tolerx, Inc., a biopharmaceutical company developing novel therapies to treat autoimmune diseases and cancer by modulating T cell activity, today announced the presentation of preclinical research describing the mechanism of action of otelixizumab at the 46th Annual Meeting of the European Association for the Study of Diabetes (EASD). In addition, Tolerx also announced that the first European patient was enrolled in DEFEND-2, a confirmatory Phase 3 clinical trial evaluating otelixizumab in autoimmune new-onset type 1 diabetes.

23 Sep 2010

PharmacoEconomics releases special issue on CER

Wolters Kluwer Pharma Solutions, a leading provider of scientific information and analytics to the pharmaceutical and biotech fields, announced today that the Adis journal PharmacoEconomics has released a special issue devoted entirely to comparative effectiveness research (CER).

23 Sep 2010

Well designed and executed care management program cuts costs: Study

A study published today in the New England Journal of Medicine shows that a carefully designed and executed care management program cuts costs.

23 Sep 2010

First Edition: September 23, 2010

A flurry of news coverage today highlights the health law's six-month anniversary and the specific provisions that take effect today, as well as the GOP's scheduled release of their "Pledge To America," which includes a repeal of the health overhaul among its priorities.

23 Sep 2010

New Canadian book helps demystify the health care system

If your usual cure for what ails you is to "take two pills and call in the morning" you might be in need of some better medical advice. Take as Directed is a new book from Dalhousie University pharmacy professor Neil MacKinnon and Dal Medical School alumni Rhonda Church. Aimed at helping Canadians from all walks of life navigate the health care system, Take as Directed is essential reading for anybody who is concerned about their health and well being.

23 Sep 2010

Use of CYPHER stent in diabetic patients can result in significant cost savings

New analysis presented at the Transcatheter Cardiovascular Therapeutics meeting (TCT 2010) in Washington, DC, indicates that the broad use of CYPHER Sirolimus-eluting coronary stent in patients with diabetes would result in substantial cost savings, as compared to the use of everolimus-eluting stents (EES), paclitaxel-eluting stents (PES), or zotarolimus-eluting stents (ZES).

23 Sep 2010

Global Strategy for Women's and Children's Health draws more than $40 billion in resources

Culminating a global summit on the Millennium Development Goals (MDGs), United Nations Secretary-General Ban Ki-moon and Heads of State and Government, along with the private sector, foundations, international organizations, civil society and research organizations, kicked off a concerted world-wide effort to save the lives of more than 16 million women and children.

23 Sep 2010

Protections for children - including young adults - in new health law cause relief and some concern

Kaiser Health News, in partnership with USA Today: "Starting tomorrow, adult children will no longer be left to fend for themselves in their search for health insurance. The new federal health law requires that insurers give parents the option of keeping their adult children covered until they're 26 years old. It becomes effective for the health policy at the beginning of the plan year.

23 Sep 2010

MDS Nordion, Isotope enter framework agreement

MDS Nordion, a leading provider of products and services to the global health science market, today announced it has entered into a framework agreement with The Open Joint Stock Company "Isotope" the authorized subsidiary of Rosatom State Corporation, to explore and define areas of collaboration in the field of supply, marketing and sale of isotopes produced in Russia.

23 Sep 2010

AFMC supports research to determine link between blood vessel anomalies and multiple sclerosis

The Association of Faculties of Medicine of Canada (AFMC), along with other organizations in Canada including the Multiple Sclerosis Society of Canada and the Canadian Institutes for Health Research, is in strong support of rigorous scientific research to determine the possible link between blood vessel anomalies and multiple sclerosis and the potential benefits of surgical intervention to relieve its symptoms.

23 Sep 2010

Raltegravir could be valid target against all Herpesviridae

Scientists at the Institute for Research in Biomedicine (IRB Barcelona) headed by the coordinator of the Structural and Computational Biology Programme, Miquel Coll, have published a new study that demonstrates that raltegravir, the drug approved in 2007 for the treatment of AIDS that is sold by Merck under the name Isentress, cancels the function of an essential protein for the replication of one kind of herpes virus.

23 Sep 2010

Over one in three diabetics do not take insulin as prescribed

More than one in three diabetes patients skip doses or fail to take their insulin as prescribed, stating that they have done so on average three times in the last month, and 77 percent of physicians estimate that in reality this number could be as high as six doses, according to the Global Attitudes of Patients and Physicians in Insulin Therapy (GAPP™) survey, released today by Novo Nordisk.

23 Sep 2010

Abbott announces positive results of bioresorbable vascular device at TCT conference

Abbott today announced positive nine-month results from the first 45 patients enrolled in the second stage of the ABSORB trial. At nine months, Abbott's bioresorbable vascular scaffold (BVS) demonstrated strong results that remained consistent with the six-month data from the same 45-patient group, with the rate of major adverse cardiac events (MACE) unchanged at 4.4 percent and no reports of blood clots (thromboses).

23 Sep 2010

LWW and Ovid enter collaboration with Joanna Briggs Institute

Wolters Kluwer Health, a leading provider of information and business intelligence for students, professionals and institutions in medicine, nursing, allied health and pharmacy, has announced an exclusive partnership with the Joanna Briggs Institute (JBI), a recognized global leader in evidence-based healthcare resources based at the University of Adelaide, Australia, as part of an expansion of the nursing, allied health, and medical content delivered to customers of products in the Lippincott Williams & Wilkins (LWW) journals and Ovid brands.

23 Sep 2010

New iPhone application for breast cancer patients

Nonprofit Breastcancer.org has launched an iPhone application for breast cancer patients. The Breast Cancer Diagnosis Guide is a free mobile app that walks users through the breast cancer pathology report a vital report that sets the patient's treatment path.

23 Sep 2010

Antibacterial ingredient in soap becomes guiding light for future development of drugs for toxoplasmosis

The antibacterial ingredient in some soaps, toothpastes, odor-fighting socks, and even computer keyboards is pointing scientists toward a long-sought new treatment for a parasitic disease that affects almost two billion people. Their report on how triclosan became the guiding light for future development of drugs for toxoplasmosis appears in ACS' monthly Journal of Medicinal Chemistry.

23 Sep 2010

Elsevier's new online surgical journal publishes case reports

Elsevier, the world-leading publisher of scientific, technical and medical information products and services together with Surgical Associates Ltd the Owner of the International Journal of Surgery, announced today the launch of the International Journal of Surgery Case Reports (IJSCR) a new author-pays online general surgical journal dedicated to publishing case reports only.

23 Sep 2010

Boehringer Ingelheim, Eurofins Medigenomix partner in DNA banking and pharmacogenetics, pharmacogenomics

Boehringer Ingelheim Pharma GmbH & Co. KG, an international research-driven pharma company, and Eurofins Medigenomix GmbH, a competence center for genetic analyses of the Eurofins Scientific Group, concluded a long-term service agreement in the area of DNA banking, as well as a master service agreement for pharmacogenetic and pharmacogenomic services. For DNA banking Eurofins Medigenomix is supporting operations of Boehringer Ingelheim's central DNA bank at Biberach an der Riss.

23 Sep 2010

Research News and Research

Study reveals elevated risk of type 2 diabetes in South Asians than other Asian immigrants

Arrowhead increases ownership in Calando Pharmaceuticals through Series A Preferred Stock exchange

Tolerx presents otelixizumab preclinical research at 46th EASD

PharmacoEconomics releases special issue on CER

Well designed and executed care management program cuts costs: Study

First Edition: September 23, 2010

New Canadian book helps demystify the health care system

Use of CYPHER stent in diabetic patients can result in significant cost savings

Global Strategy for Women's and Children's Health draws more than $40 billion in resources

Protections for children - including young adults - in new health law cause relief and some concern

MDS Nordion, Isotope enter framework agreement

AFMC supports research to determine link between blood vessel anomalies and multiple sclerosis

Raltegravir could be valid target against all Herpesviridae

Over one in three diabetics do not take insulin as prescribed

Abbott announces positive results of bioresorbable vascular device at TCT conference

LWW and Ovid enter collaboration with Joanna Briggs Institute

New iPhone application for breast cancer patients

Antibacterial ingredient in soap becomes guiding light for future development of drugs for toxoplasmosis

Elsevier's new online surgical journal publishes case reports

Boehringer Ingelheim, Eurofins Medigenomix partner in DNA banking and pharmacogenetics, pharmacogenomics

eBook: Advancing neurodegenerative research with iPSC-derived microglia models eBook

Latest eBooks

A practical guide to lipid nanoparticle formulation and resizing

Editorial Focus eBook - Spatial and single-cell omics (1st edition)

Industry Focus eBook - Analytical Chemistry (3rd edition)

Industry Focus eBook - Microbiome (1st edition)

Improving healthcare sustainability through carbon data

Managing vibration in IVF laboratories

A New Approach to Preventing Bladder Cancer Recurrence